From: Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
Type of Cancer | Early/ Locally Advanced (n =) | Refractory/ Metastatic (n =) | All Stages (n =) | Total Number of Studies | Percentage of Total Studies (%) |
---|---|---|---|---|---|
Breast Cancer | 5 | 6 | 1 | 12 | 15.8 |
Pancreatic Cancer | 3 | 3 | 4 | 10 | 13.1 |
Colorectal Cancer | 3 | 3 | 3 | 9 | 11.8 |
Lung Cancer | 2 | 2 | 4 | 8 | 10.5 |
Different Gastrointestinal Cancers | 3 | 2 | 0 | 5 | 6.6 |
Esophageal Cancer | 1 | 2 | 0 | 3 | 3.9 |
Biliary Tract Cancer | 2 | 1 | 0 | 3 | 3.9 |
Kidney Cancer | 2 | 1 | 0 | 3 | 3.9 |
Ovarian Cancer | 0 | 2 | 1 | 3 | 3.9 |
Different Reproductive Cancers | 1 | 2 | 0 | 3 | 3.9 |
Any Cancer Type | 0 | 3 | 1 | 4 | 5.3 |
Liver Cancer | 1 | 1 | 0 | 2 | 2.6 |
Glioblastoma | 1 | 1 | 0 | 2 | 2.6 |
Neuroendocrine Carcinoma | 0 | 1 | 1 | 2 | 2.6 |
Sarcoma | 1 | 1 | 0 | 2 | 2.6 |
Different Head and Neck Cancers | 1 | 0 | 1 | 2 | 2.6 |
Multiple Myeloma | 0 | 0 | 1 | 1 | 1.3 |
Prostatic Cancer | 0 | 1 | 0 | 1 | 1.3 |
Bladder Cancer | 1 | 0 | 0 | 1 | 1.3 |